TRDA Stock-Based Compensation
Entrada Therapeutics Inc · Stock-Based Compensation
TRDA Stock-Based Compensation
Latest reported$19.37Mperiod ending
TRDA TTM Stock-Based Comp ($325.00K → $19.37M)
TTM stock-based compensation
High-resolution chart · PNG
TRDA stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 19,368,000 | |
| 19,266,000 | |
| 19,609,000 | |
| 19,951,000 | |
| 19,695,000 | |
| 19,269,000 | |
| 17,915,000 | |
| 17,056,000 | |
| 15,592,000 | |
| 14,089,000 | |
| 13,111,000 | |
| 12,152,000 | |
| 11,463,000 | |
| 10,856,000 | |
| 9,895,000 | |
| 8,471,000 | |
| 6,342,000 | |
| 4,156,000 | |
| 2,526,000 | |
| 1,166,000 | |
| 663,000 | |
| 413,000 | |
| 325,000 |